Month: September 2021

In case you missed it, here were the top news stories on MD+DI for September 2021: Can Abbott Succeed Where Boston Sci Has Failed?Boston Scientific’s attempt to compete in transcatheter aortic valve replacement (TAVR) didn’t work out so well. Will Abbott meet the same fate? Zimmer Biomet Unveils Leadership Team Behind ZimVie SpinoutThe dental and spine businesses spin-out
0 Comments
A team at Concordia University in Montreal have developed a technique called Laser-Induced Side Transfer (LIST) that allows for bioprinting of neurons. Low energy laser pulses are directed at a capillary containing a cell-laden bioink, resulting in microbubbles that eject a microjet of the ink onto the substrate below. The technique appears to be fairly
0 Comments
Simens just scored FDA clearance for a device that uses the emerging CT imaging technology of photon-counting detectors which can measure each individual X-ray that passes through a patient’s body, as opposed to current systems which use detectors that measure the total energy contained in many X-rays at once. By ‘counting’ each individual X-ray photon, more detailed
0 Comments
Video highlights of COVID-19 data trends as of September 30, 2021. Explore COVID-19 trends around the world with our in-depth data tracking: New cases and cumulative cases: https://coronavirus.jhu.edu/data/cumulative-cases Daily new cases, testing, and positivity ratio by U.S. state: https://coronavirus.jhu.edu/testing/tracker/overview New cases by country: https://coronavirus.jhu.edu/data/new-cases
0 Comments
Latest Diabetes News By Dennis Thompson HealthDay Reporter TUESDAY, Sept. 28, 2021 (HealthDay News) A drug widely used to treat osteoporosis might reduce the risk of type 2 diabetes, a new study suggests. Taking the drug alendronate (Fosamax) for at least eight years could potentially reduce a person’s risk of type 2 diabetes by more
0 Comments
Latest Coronavirus News WEDNESDAY, Sept. 29, 2021 Pfizer Inc. announced Tuesday that it has submitted initial data to federal regulators on the efficacy of its COVID-19 vaccine among younger children. The company is also expected to submit the same data on kids aged 5 to 11 to the European Medicines Agency and other regulatory authorities
0 Comments
Jeff Shuren, director of FDA’s Center for Devices and Radiological Health, and his colleagues shared a number of key medical device updates during the annual CDRH Town Hall at The MedTech Conference by AdvaMed. The 2021 virtual session was moderated by Janet Trunzo, AdvaMed’s senior advisor to the president and senior executive vice president, technology
0 Comments
A non-invasive, patient-friendly imaging technique can help physicians make treatment decisions for breast cancer patients when diagnostic dilemmas arise. The 18F-FES PET scan-;approved by the U.S. Food and Drug Administration in 2020-;was shown to solve 87 percent of dilemmas, providing physicians with information for personalized treatment decision-making. This research was published in the September issue
0 Comments
Insurers and investors are pouring funding into Wayspring, a recently renamed startup providing services to help people navigate treatment for substance use disorder. The Nashville-based company recently closed a $75 million funding round led by Valtruis, a  new subsidiary of private equity firm Welsh, Carson, Anderson & Stowe (WCAS)  that invests in value-based care companies.
0 Comments
Researchers at the University of Freiburg in Germany have developed a chip that can measure antibiotic levels in breath, potentially paving the way for rapid point-of-care antibiotic testing. Attaining the correct levels of antibiotics in the body is crucial to effectively treating infections and avoiding drug side-effects or the development of antibiotic-resistant bacteria. The chip
0 Comments
Since the first reported coronavirus disease 2019 (COVID-19) case in December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome has continued to mutate and evolve. Some mutations in the SARS-CoV-2 genome might influence the development of effective intervention strategies. Study: Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of
0 Comments
Video highlights of COVID-19 data trends as of September 29, 2021. Explore COVID-19 trends around the world with our in-depth data tracking: New cases and cumulative cases: https://coronavirus.jhu.edu/data/cumulative-cases Daily new cases, testing, and positivity ratio by U.S. state: https://coronavirus.jhu.edu/testing/tracker/overview New cases by country: https://coronavirus.jhu.edu/data/new-cases
0 Comments